Select Page

Congratulations to SBRC alumnus, Dr. Josette Northcott, Senior Manager, Assay R&D at Personalis.   

Personalis hit the #1 spot on The Scientist ranking for Top 10 innovations for 2022 for a new product that uses a patient’s own tumors to detect, quantify and monitor circulating tumor DNA in order to spot molecular residual disease (MRD) and track responses to therapy.

Northcott was a PhD student who trained under Dr. Jeff Wigle from 2004-2012 here at St. Boniface Hospital Albrechtsen Research Centre. “It was a great joy to be Josette’s mentor her at the SBRC.   She has built on her training from here and has gone on to excel both in academic research and in industry.  Her role in leading the development and implementation of a new clinical diagnostic assay is a very impressive accomplishment,” Dr. Wigle shared.

As a member of the team working on the NeXT Personal technology, Dr. Northcott shared that they are very excited by this product launch. 

Dr. Josette Northcott in her student days
Dr. Northcott (pictured here @2012) trained under Dr. Jeff Wigle, Principal Investigator
Vascular Development, Institute of Cardiovascular Sciences, Associate Professor Department of Biochemistry and Medical Genetics